NCT00960635
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
- Locations
-
- Institut fuer Diabetesforschung Munich, Germany
Clinical trial condition
Diabetes Mellitus, Type 1
Explore clinical trials studying Diabetes Mellitus, Type 1. Study availability and eligibility vary by location and protocol.
2,858 public trials
318 recruiting studies
Diabetes Mellitus, Type 1 trial results
NCT00947635
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +9 more
- Locations
-
- University of Alberta Edmonton, Alberta, Canada
NCT00337298
- Conditions
- Autoimmune Diseases, Cardiovascular Diseases, Diabetes Complications, +13 more
- Locations
-
- Aarhus university hospital Aarhus, Denmark
NCT00420095
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guangzhou, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hangzhou, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Harbin, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hefei, China
Completed
Glulisine + Lantus in Type I Patients
NCT00546702
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
- Locations
-
- Sanofi-aventis Moscow, Russia
Completed
Effect of Immediate Hemoglobin A1c on Glycemic Control in Children With Type I Diabetes Mellitus
NCT00898534
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +7 more
- Locations
-
- Children's Hospital Boston Boston, Massachusetts, United States
NCT00460304
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
- Locations
-
Not specified
NCT00873561
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
- Locations
-
- Children's Hospital of Eastern Ontario Ottawa, Ontario, Canada
- Center Hospitalier Universitaire de Sherbrooke Sherbrooke, Quebec, Canada
- Centre de recherche clinique de Laval Laval, Canada
- University Hospital and School of Medicine Olomouc, Czechia
Completed
APIDRA Registration Study
NCT00489190
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
- Locations
-
- Sanofi-Aventis Almaty, Kazakhstan
NCT00497536
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
- Locations
-
- Medicinsk Endokrinologisk Afdeling M Aarhus C, Central Jutland, Denmark